01 6Strattera
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 739
2014 Revenue in Millions : 784
Growth (%) : 6%
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 4.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 855
2015 Revenue in Millions : 784
Growth (%) : 9
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 618
2016 Revenue in Millions : 855
Growth (%) : -28
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 451
2017 Revenue in Millions : 618
Growth (%) : -27%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 243
2018 Revenue in Millions : 451
Growth (%) : -46
LOOKING FOR A SUPPLIER?